SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpel Priv Eqty Regulatory News (JPEL)

Share Price Information for Jpel Priv Eqty (JPEL)

Share Price is delayed by 15 minutes
Get Live Data
1.24    0.00 (0.00%)
Bid:
1.20
Ask:
1.28
Spread: 0.08 (6.667%)
Market Cap: $21.21m
JPEL Live PriceLast checked at - London Stock Exchange

Intraday Jpel Priv Eqty Share Chart

Tender Offer

18 Jan 2012 09:16

RNS Number : 7565V
J.P. Morgan Private Equity Ltd
18 January 2012
 



 

 

Announcement of Tender Offer Electionsto Purchase Shares as at 31 December 2011

 

* * *

 

GUERNSEY, 18 JANUARY 2012

 

The Company is pleased to announce that based on the total number of Shares tendered as part of the Company's Tender Offer to purchase shares at the prevailing Net Asset Value as at 31 December 2011, the Board anticipates that the Company will:

 

·; Accept 10,706,290 of all US$ Equity Shares tendered (amounting to 3% of US$ Equity Shares outstanding as at the date of the publication of the tender offer circular and 4.5% of the 238,547,562 US$ Equity Shares tendered);

·; Accept all 153,284 2013 ZDP Shares tendered (amounting to 0.2% of 2013 ZDP Shares outstanding as at the date of the publication of the tender offer circular and 100% of all 153,284 2013 ZDP Shares tendered); and

·; Accept all 1,514,935 2015 ZDP Shares tendered (amounting to 2.2% of 2015 ZDP Shares outstanding as at the date of the publication of the tender offer circular and 100% of all 1,514,935 2015 ZDP Shares tendered).

 

The Basic Entitlement of each US$ Equity Shareholder, 2013 ZDP Shareholder and 2015 ZDP Shareholder equates to 3 shares of the relevant class per 100 shares of the relevant class in issue at 7 June 2011 (excluding Shares held in treasury) when the tender authority was granted to the Board of Directors. US$ Equity Shares tendered in excess of the 3% Basic Entitlement will be scaled back on a pro rata basis and the resulting number of US$ Equity Shares will be purchased.

 

US$ Equity Shares not accepted under the Tender Offer will be returned to the applicable CREST accounts by Capita Registrars in the week commencing on Monday, 16 January 2012, at which time shareholders will be free to deal in such US$ Equity Shares, while the Shares accepted under the Tender Offer shall remain in escrow until the purchase date, which is anticipated to be 24 February 2012, at a price which will set by reference to the prevailing Net Asset Value of the Company's portfolio as of 31 December 2011.

 

Payments to Shareholders by cheque, in the case of certificated holders, will be despatched by 24 February 2012. Payments through CREST, in the case of uncertificated holders, will be made on or around 24 February 2012. Balancing share certificates will be dispatched and CREST accounts settled on or around 24 February 2012.

Shareholders with any questions in relation to the Tender Offer or about the amount of their US$ Equity Shares not accepted for tender should contact the Capita Registrars helpline number on 0871 664 0321 from within the UK or +44 20 8639 3399 if calling from outside the UK between 9.00 a.m. and 5.00 p.m. (London time) Monday to Friday. Calls to the 0871 664 0321 number cost 10 pence per minute from a BT landline. Other network providers' costs may vary. Calls to the helpline from outside the UK will be charged at applicable international rates. Different charges may apply to calls from mobile telephones and calls may be recorded and randomly monitored for security and training purposes. The helpline cannot provide advice on the merits of the Tender Offer nor give any financial, legal or tax advice.

 

Definitions and terms defined in the Circular of 17 November 2011 have the same meaning when used herein unless the context otherwise requires.

 

For further information please contact:

 

J.P. Morgan Private Equity Limited

Troy Duncan / Greg Getschow

+44 (0)20 7742 9203 / +1 212 648 1150

Troy.duncan@jpmorgan.com / Gregory.getschow@jpmorgan.com

 

 

Rosemary DeRise / Samantha Ladd

+1 212 648 2980 / +1 212 648 2982

Rosemary.DeRise@jpmorgan.com / Samantha.Ladd@jpmorgan.com

 

 

* * *

 

About J.P. Morgan Private Equity Limited

 

J.P. Morgan Private Equity Limited is a Guernsey registered and incorporated, London Stock Exchange-listed, closed-ended investment company (LSE: JPEL, JPWW, JPEZ, JPZZ, JPSZ) designed primarily to invest in the global private equity market. The investment objective of the Company is to achieve both short and long-term capital appreciation by investing in a well diversified portfolio of private equity fund interests and by capitalising on the inefficiencies of the secondary private equity market.

 

 

END

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TENEANFPFFSAEEF
Date   Source Headline
2nd Jun 20269:29 amRNSNet Asset Value - March 2026
23rd Apr 20267:00 amRNSJoint Broker Appointment
14th Apr 20267:00 amRNSAppointment of Directors
6th Mar 20265:59 pmRNSHalf-year Financial Report - December 2025
14th Jan 20269:53 amRNSCOMPLETION OF THIRTEENTH MANDATORY REDEMPTION
29th Dec 20253:18 pmRNSTHIRTEENTH MANDATORY REDEMPTION
19th Dec 20255:53 pmRNSNet Asset Value September 2025
2nd Dec 20254:44 pmRNS2025 AGM Results Statement
10th Nov 202512:19 pmRNS2025 AGM Circular Statement
5th Nov 20254:07 pmRNSHolding(s) in Company
3rd Nov 20254:30 pmRNSHolding(s) in Company
3rd Nov 20254:11 pmRNSHolding(s) in Company
30th Oct 20257:00 amRNSAnnual Financial Report 2025
22nd Jul 20257:00 amRNSAppointed Sole Corp. Broker & Financial Adviser
10th Jun 20254:47 pmRNSNet Asset Value - March 2025
1st May 20256:11 pmRNSHolding(s) in Company
18th Mar 20255:04 pmRNSHalf-year Report - December 2024
3rd Dec 20242:30 pmRNSNet Asset Value September 2024
27th Nov 20245:16 pmRNS2024 AGM Results
6th Nov 20247:00 amRNS2024 AGM Circular
25th Oct 20247:00 amRNSPortfolio Update
25th Oct 20247:00 amRNSAnnual Financial Report - 2024
5th Jun 20247:00 amRNSNet Asset Value - March 2024
23rd Apr 20245:18 pmRNSDirector Declaration
15th Mar 20246:15 pmRNSNet Asset Value - December 2023
15th Mar 20246:03 pmRNSHalf-year Report - December 2023
15th Mar 20243:50 pmRNSHalf-year Report - 2023
6th Dec 20235:36 pmRNSDirector Declaration
6th Dec 20235:33 pmRNSAGM RESULTS 2023
9th Nov 202311:56 amRNS2023 AGM CIRCULAR
8th Nov 20237:00 amRNSCompletion of Twelfth Mandatory Redemption
24th Oct 20237:00 amRNSTwelfth Mandatory Redemption & Shareholder Update
20th Oct 202310:28 amRNSNet Asset Value - September 2023
21st Sep 20235:33 pmRNSNet Asset Value(s) - June 2023
21st Jun 20233:36 pmRNSDirectorate Change
12th May 20231:46 pmRNSNet Asset Value(s) - March 2023
28th Mar 20233:32 pmRNSHalf-year Report - 31 December 2022
14th Mar 20234:35 pmRNSPrice Monitoring Extension
14th Mar 20232:05 pmRNSSecond Price Monitoring Extn
14th Mar 20232:00 pmRNSPrice Monitoring Extension
14th Mar 202311:05 amRNSSecond Price Monitoring Extn
14th Mar 202311:00 amRNSPrice Monitoring Extension
14th Mar 20239:05 amRNSSecond Price Monitoring Extn
14th Mar 20239:00 amRNSPrice Monitoring Extension
24th Feb 20234:22 pmRNSNet Asset Value(s) - December 2022
13th Feb 20234:51 pmRNSDirector Declaration
22nd Dec 20227:00 amRNSCompletion of Eleventh Mandatory Redemption
14th Dec 20227:00 amRNSELEVENTH MANDATORY REDEMPTION & SHAREHOLDER UPDATE
13th Dec 20225:09 pmRNSDirectorate Change
29th Nov 20224:33 pmRNSAGM Results 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.